Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RecruitingNCT06511141Phase: NAStarted 2024-10-22
Summary
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Eligibility
Sex
MALE
Min Age
18 Years
Max Age
None
Locations
University of Alabama at BirminghamBirmingham, Alabama, United States
Urology AssociatesFairhope, Alabama, United States
Mayo ClinicScottsdale, Arizona, United States
El Camino HealthMountain View, California, United States
Tri Valley UrologyMurrieta, California, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06511141